Gladstone Institutional Advisory’s John Hancock Multifactor Healthcare ETF JHMH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,831
Closed -$338K 703
2022
Q3
$338K Buy
7,831
+194
+3% +$8.96K 0.03% 468
2022
Q2
$348K Sell
7,637
-280
-4% -$13.1K 0.03% 477
2022
Q1
$392K Buy
7,917
+3,540
+81% +$170K 0.03% 482
2021
Q4
$227K Buy
+4,377
New +$217K 0.02% 536

Gladstone Institutional Advisory's JHMH Position: Q4 2022 in Review

Gladstone Institutional Advisory sold out of John Hancock Multifactor Healthcare ETF (JHMH) in Q4 2022, closing a stake of 7,831 shares — an estimated $338K sold.

Gladstone Institutional Advisory first reported a position in JHMH in Q4 2021 and held it in 4 quarters. The position peaked at $392K in Q1 2022. 0 funds tracked by Wall St. Rank hold JHMH as of Q4 2022.

  • Gladstone Institutional Advisory reported no remaining John Hancock Multifactor Healthcare ETF position as of Q4 2022 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 7,831 John Hancock Multifactor Healthcare ETF shares in Q4 2022, an estimated $338K.
  • Gladstone Institutional Advisory first reported a position in John Hancock Multifactor Healthcare ETF in Q4 2021 and held it in 4 quarters.
  • Gladstone Institutional Advisory's John Hancock Multifactor Healthcare ETF position peaked at $392K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held John Hancock Multifactor Healthcare ETF as of Q4 2022.

Based on Gladstone Institutional Advisory's 13F filing for Q4 2022, filed 1 Feb 2023.